Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ECT Modified by Atracurium.

Frederick G. Hicks1

  • 1Washington University School of Medicine, Department of Psychiatry, St. Louis, Missouri, USA.

Convulsive Therapy
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Electroconvulsive therapy (ECT) is safe, but succinylcholine can cause issues. Atracurium offers a safe alternative for muscle relaxation in ECT patients with specific medical conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Wilson's disease, psychosis, and ECT.

Convulsive therapy·1998
Same journal

Maintenance electroconvulsive therapy for Parkinson's disease.

Convulsive therapy·1998
Same journal

Multiple ECT late in the course of neuroleptic malignant syndrome.

Convulsive therapy·1998
Same journal

Prejudice against ECT: competition with psychological philosophies as a contribution to its stigma.

Convulsive therapy·1998
Same journal

Quantifying utilization and practice variation of electroconvulsive therapy.

Convulsive therapy·1998
Same journal

Electroconvulsive therapy consultation: an update.

Convulsive therapy·1998
See all related articles

Area of Science:

  • Anesthesiology
  • Neurology
  • Pharmacology

Background:

  • Electroconvulsive therapy (ECT) is a common psychiatric treatment.
  • Succinylcholine is a standard muscle relaxant used in ECT protocols.
  • Certain medical conditions can complicate succinylcholine administration.

Purpose of the Study:

  • To present cases where atracurium was used as an alternative to succinylcholine in ECT.
  • To highlight atracurium as a viable option for muscle relaxation in specific patient populations undergoing ECT.

Main Methods:

  • Review of three clinical cases.
  • Modification of standard ECT protocol to substitute atracurium for succinylcholine.
  • Monitoring of muscle relaxation and patient response.

Related Experiment Videos

Main Results:

  • Atracurium provided effective and controlled muscle relaxation in all three cases.
  • No adverse events related to atracurium administration were reported.
  • Successful ECT was performed with the modified protocol.

Conclusions:

  • Atracurium is a safe and effective alternative muscle relaxant for ECT when succinylcholine is contraindicated or problematic.
  • This approach expands treatment options for patients with specific neuromuscular conditions undergoing ECT.
  • Careful patient selection and pharmacological choice are crucial for safe ECT administration.